Your session is about to expire
← Back to Search
Diagnostic Test
Study Groups for Coronavirus Pandemic
N/A
Waitlist Available
Research Sponsored by 3EO Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-16 weeks
Awards & highlights
Study Summary
This trial is testing a new COVID-19 test to see if it's accurate. Nasal samples will be collected and compared to results from another, already established test.
Eligible Conditions
- Coronavirus Pandemic
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation of the 3EO Health SARS-CoV-2 standard of care (PCR) Zymo rRT-PCR results of the anterior nare sample.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Study GroupsExperimental Treatment1 Intervention
Positives: Symptomatic vs. Asymptomatic Negatives: Symptomatic vs. Asymptomatic
Each broken down by age groups:
2-14 years old 15-24 years old 25-64 years old 65+ years old
Find a Location
Who is running the clinical trial?
3EO HealthLead Sponsor
1 Previous Clinical Trials
202 Total Patients Enrolled
Jerika AcostaStudy DirectorMedicept Inc
1 Previous Clinical Trials
202 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger